Microscopic polyangiitis as lung-kidney syndrome. Case reportort
Keywords:
granulomatosis with polyangiitis, anti-glomerular basement membrane disease, vasculitisAbstract
Introduction: Lung-kidney syndrome is a rare, severe, but highly fatal manifestation of primary systemic small-vessel vasculitis. It is characterized histologically by pulmonary and renal capillaritis and clinically by rapidly progressive glomerulonephritis. Among ANCA-associated vasculitis (AAV), a group of autoimmune diseases affecting small and medium-sized blood vessels, microscopic polyangiitis (MPA), associated with MPO-ANCA, can manifest as lung-kidney syndrome.
Case report: a 22-year-old woman with no prior medical history, presenting with a one-month history of abdominal pain, nausea, vomiting, asthenia, and hyporexia. Laboratory tests revealed anemia, acute kidney injury, hematuria, and proteinuria. Chest tomography showed bilateral pulmonary infiltrates. Renal biopsy confirmed pauci-immune extracapillary proliferative glomerulonephritis. A diagnosis of MPA with pulmonary-renal syndrome phenotype was established, and treatment was initiated with methylprednisolone and rituximab, followed by maintenance therapy with azathioprine and progressive dose reduction of prednisone.
Conclusions: early and accurate diagnosis of AAV is crucial for proper management and prognosis. The combination of glucocorticoids and immunosuppressants significantly improves survival and disease remission. This case highlights the importance of a multidisciplinary approach and the use of biomarkers for the rapid identification and treatment of MPA.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Goethe Salomón Sacoto Flores, Mayra Soledad Huillcatanda Sacasari

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright © Autors.

You are free to:
![]() |
Share — copy and redistribute the material in any medium or format |
![]() |
Adapt — remix, transform, and build upon the material for any purpose, even commercially. |
Under the following conditions:
![]() |
Attribution — You must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licenser endorses you or your use. |
| NonCommercial — You may not use the material for commercial purposes. | |
| ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. |
| No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the licence permits. |






